We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Is Your API Ready for GMP Scale Up?

Is Your API Ready for GMP Scale Up? content piece image

Developing a small molecule active pharmaceutical ingredient (API) is often a risky process. Reaching the goal, be it first in human studies or commercial manufacture, requires data and material without incurring unnecessary delays or impact on costs. Therefore, it’s important to start thinking about process steps and scalability early.

Watch this webinar to learn about:

  • How to assess your process, from safety to efficiency and robustness, as well as understanding the solid form
  • The importance of having strong analytical methods to detect impurities and understand their impact
  • What supporting analytical data is required prior to good manufacturing practice
A picture of David Fengas
David Fengas
Director of CMC Services
A picture of Caroline German
Caroline German
Technical Director, Concept Life Sciences